IMP2 is implicated in polycystic ovarian syndrome (PCOS), a condition typified by infertility, inflammation, irregular menstrual cycles, multiple ovarian cysts, and an increased risk of progression to ovarian cancer [37]. This evidence concerns the gene IGF2BP2 and ovarian cancer.